These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24574775)

  • 1. Novel esophageal squamous cell carcinoma bone metastatic clone isolated by scintigraphy, X ray and micro PET/CT.
    Zhao BZ; Cao J; Shao JC; Sun YB; Fan LM; Wu CY; Liang S; Guo BF; Yang G; Xie WH; Yang QC; Yang SF
    World J Gastroenterol; 2014 Jan; 20(4):1030-7. PubMed ID: 24574775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy.
    Yang S; Dong Q; Yao M; Shi M; Ye J; Zhao L; Su J; Gu W; Xie W; Wang K; Du Y; Li Y; Huang Y
    Nucl Med Biol; 2009 Apr; 36(3):313-21. PubMed ID: 19324277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of a novel chinese human lung adenocarcinoma cell line CPA-Yang3 and its real bone metastasis clone CPA-Yang3BM in immunodeficient mice].
    Yang S; Shi M; Cao J; Su J; Zhao L; Lei B; Chang C; Lu J; Ye J; Xie W
    Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):79-85. PubMed ID: 21342638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA
    Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2005; 25(6C):4439-44. PubMed ID: 16334123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Bone Metastases between
    Wang D; Yang Y; Zeng Z; Ye J; Guo C; Huang S; Guo X; Xiao J
    Contrast Media Mol Imaging; 2022; 2022():5975338. PubMed ID: 35494210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A; Mittra E; Dick DW; Gambhir SS
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging.
    Pires AO; Borges US; Lopes-Costa PV; Gebrim LH; da Silva BB
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():138-41. PubMed ID: 25037283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of
    Wang X; Liu G; Li Z; Shi J; Liang M; Fu G; Lv L; Ju S; Wang Y; Xu W; Wang F; Cao Q; Shan H
    Thorac Cancer; 2024 Sep; 15(27):1958-1967. PubMed ID: 39140206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
    Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
    Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma.
    Byun BH; Kong CB; Lim I; Kim BI; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    Skeletal Radiol; 2013 Dec; 42(12):1673-81. PubMed ID: 23995264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?
    Yang Z; Zhang Y; Shi W; Zhu B; Hu S; Yao Z; Pan H; Hu C; Zhang Y; Li D
    Ann Nucl Med; 2014 Jun; 28(5):411-6. PubMed ID: 24610681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
    Liu CJ; Cheng JC; Lee JM; Cheng MF; Tzen KY; Yen RF
    Clin Nucl Med; 2015 May; 40(5):384-9. PubMed ID: 25674870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.
    Heidari P; Esfahani SA; Turker NS; Wong G; Wang TC; Rustgi AK; Mahmood U
    J Nucl Med; 2015 Aug; 56(8):1246-51. PubMed ID: 26069303
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wei XF; Chen XK; Lu L; Luo P; Xu L; Xie HN; Yang YF; Yu YK; Li HM; Liu Q; Zhang RX; Qin JJ; Li Y
    Thorac Cancer; 2022 Aug; 13(16):2371-2376. PubMed ID: 35811377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.